# Contineum Therapeutics, Inc.: Form 8-K, filed Sep 14, 2026

- Company: [Contineum Therapeutics, Inc.](/companies/ctnm.md) (CIK 1855175)
- Form: 8-K
- Filed: 2026-09-14
- Accepted by EDGAR: Sep 14, 2026, 20:07 ET
- Period: 2026-09-14
- Accession: 0001628280-26-061834
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1855175/000162828026061834/ctnm-20260914.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1855175/000162828026061834/

## Items reported

- Item 8.01: Other events
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1855175/000162828026061834/ctnm-20260914.htm

Filed Sep 14, 2026.
Source: SEC EDGAR, the filing index for accession 0001628280-26-061834. Last ingested by Listed: Oct 24, 2026, 15:06 ET. No prices; not investment advice.